Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vigabatrin in adults with poorly-controlled epilepsy and learning disabilities.

D J Armour1, C Fidler, E C Wright

  • 1St Lawrence's Hospital, Caterham, Surrey, UK.

Seizure
|September 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Activation of kappa opioid receptors in the dorsal raphe have sex dependent effects on social behavior in California mice" [Behav. Brain Res. 351 (2018) 83-92].

Behavioural brain research·2018
Same author

Exposure to extrinsic stressors, social defeat or bisphenol A, eliminates sex differences in DNA methyltransferase expression in the amygdala.

Journal of neuroendocrinology·2017
Same author

Postweaning nutritional programming of ovarian development in beef heifers.

Journal of animal science·2015
Same author

Age at puberty, ovulation rate, and uterine length of developing gilts fed two lysine and three metabolizable energy concentrations from 100 to 260 d of age.

Journal of animal science·2015
Same author

Effect of elevated ambient temperature at parturition on duration of gestation, ruminal temperature, and endocrine function of fall-calving beef cows.

Journal of animal science·2014
Same author

Maintenance energy requirements of beef cows and relationship with cow and calf performance, metabolic hormones, and functional proteins.

Journal of animal science·2014
Same journal

Efficacy, tolerability, and EEG lateralization-based predictors of neuropsychiatric adverse events in pediatric SeLECTS treated with perampanel monotherapy.

Seizure·2026
Same journal

Cross-cultural validation of the International Classification of Cognitive Disorders in Epilepsy (IC-CoDE) in Chinese-speaking people with epilepsy.

Seizure·2026
Same journal

Unlocking seizure freedom: A European Delphi panel study on the clinical, humanistic, and economic value of seizure control in epilepsy.

Seizure·2026
Same journal

RLIM variant associated with X-linked epilepsy with neurodevelopmental disorders and the molecular sub-regional effects.

Seizure·2026
Same journal

Association between disconnected networks and surgical outcome in drug-resistant temporal lobe epilepsy.

Seizure·2026
Same journal

Healthcare resource utilization and persistence in children and adults with Dravet syndrome receiving fenfluramine: a retrospective analysis using United States claims data.

Seizure·2026
See all related articles

Vigabatrin effectively reduced seizure frequency by a median of 49% in adults with difficult-to-treat epilepsy. This add-on therapy proved beneficial for 45% of patients, with some able to reduce other antiepileptic drugs.

Area of Science:

  • Neurology
  • Epileptology
  • Pharmacology

Background:

  • Epilepsy in adults with severe learning difficulties is often difficult to manage.
  • Standard antiepileptic drug (AED) treatments may be insufficient for these complex cases.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of vigabatrin as an add-on therapy in adults with uncontrolled epilepsy and severe learning difficulties.
  • To assess the impact of vigabatrin on seizure frequency and the potential for reducing other AEDs.

Main Methods:

  • An open-label study included 22 adult patients with uncontrolled epilepsy and severe learning difficulties.
  • Vigabatrin was added to existing AED regimens, with doses titrated up to 4 g/day.
  • Seizure frequency was monitored during a baseline period and a 4-month dose titration phase.

Related Experiment Videos

Main Results:

  • Median seizure frequency reduction was 49% (P = 0.014) in patients with baseline seizures.
  • Over 50% seizure reduction was achieved by 10 patients during dose titration.
  • Vigabatrin was effective as add-on therapy in 45% of patients; 3 patients successfully had other AEDs withdrawn.

Conclusions:

  • Vigabatrin is an effective add-on treatment for a significant proportion of adults with difficult-to-treat epilepsy and severe learning difficulties.
  • The medication was generally well-tolerated, with no patient withdrawals due to adverse events.
  • Vigabatrin offers a valuable therapeutic option, potentially allowing for the reduction of other AEDs in select patients.